182 related articles for article (PubMed ID: 15047687)
1. Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals.
Hui TY; Sheth SS; Diffley JM; Potter DW; Lusis AJ; Attie AD; Davis RA
J Biol Chem; 2004 Jun; 279(23):24387-93. PubMed ID: 15047687
[TBL] [Abstract][Full Text] [Related]
2. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production.
Chutkow WA; Patwari P; Yoshioka J; Lee RT
J Biol Chem; 2008 Jan; 283(4):2397-406. PubMed ID: 17998203
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis.
Chen J; Saxena G; Mungrue IN; Lusis AJ; Shalev A
Diabetes; 2008 Apr; 57(4):938-44. PubMed ID: 18171713
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function.
Oka S; Yoshihara E; Bizen-Abe A; Liu W; Watanabe M; Yodoi J; Masutani H
Endocrinology; 2009 Mar; 150(3):1225-34. PubMed ID: 18974273
[TBL] [Abstract][Full Text] [Related]
6. SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice.
Qin K; Zhang N; Zhang Z; Nipper M; Zhu Z; Leighton J; Xu K; Musi N; Wang P
Diabetologia; 2018 Apr; 61(4):906-918. PubMed ID: 29322219
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic β-cells.
Luo Y; He F; Hu L; Hai L; Huang M; Xu Z; Zhang J; Zhou Z; Liu F; Dai YS
PLoS One; 2014; 9(6):e99049. PubMed ID: 24897113
[TBL] [Abstract][Full Text] [Related]
9. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
[TBL] [Abstract][Full Text] [Related]
10. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin binding protein-2 inhibits excessive fetal hypoglycemia during maternal starvation by suppressing insulin secretion in mice.
Mogami H; Yura S; Tatsumi K; Fujii T; Fujita K; Kakui K; Kondoh E; Inoue T; Fujii S; Yodoi J; Konishi I
Pediatr Res; 2010 Feb; 67(2):138-43. PubMed ID: 19809375
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes.
Chen J; Hui ST; Couto FM; Mungrue IN; Davis DB; Attie AD; Lusis AJ; Davis RA; Shalev A
FASEB J; 2008 Oct; 22(10):3581-94. PubMed ID: 18552236
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis.
Minn AH; Hafele C; Shalev A
Endocrinology; 2005 May; 146(5):2397-405. PubMed ID: 15705778
[TBL] [Abstract][Full Text] [Related]
14. Txnip contributes to impaired glucose tolerance by upregulating the expression of genes involved in hepatic gluconeogenesis in mice.
Jo SH; Kim MY; Park JM; Kim TH; Ahn YH
Diabetologia; 2013 Dec; 56(12):2723-32. PubMed ID: 24037087
[TBL] [Abstract][Full Text] [Related]
15. Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets.
Shaked M; Ketzinel-Gilad M; Ariav Y; Cerasi E; Kaiser N; Leibowitz G
Diabetologia; 2009 Apr; 52(4):636-44. PubMed ID: 19214472
[TBL] [Abstract][Full Text] [Related]
16. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement.
Ono H; Shimano H; Katagiri H; Yahagi N; Sakoda H; Onishi Y; Anai M; Ogihara T; Fujishiro M; Viana AY; Fukushima Y; Abe M; Shojima N; Kikuchi M; Yamada N; Oka Y; Asano T
Diabetes; 2003 Dec; 52(12):2905-13. PubMed ID: 14633850
[TBL] [Abstract][Full Text] [Related]
18. The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression.
Stoeckman AK; Towle HC
J Biol Chem; 2002 Jul; 277(30):27029-35. PubMed ID: 12016216
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
[TBL] [Abstract][Full Text] [Related]
20. A modest glucokinase overexpression in the liver promotes fed expression levels of glycolytic and lipogenic enzyme genes in the fasted state without altering SREBP-1c expression.
Scott DK; Collier JJ; Doan TT; Bunnell AS; Daniels MC; Eckert DT; O'Doherty RM
Mol Cell Biochem; 2003 Dec; 254(1-2):327-37. PubMed ID: 14674713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
